Lv51
1000 积分 2023-07-30 加入
Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study
14小时前
待确认
Diverse approaches and sources to derive antitumor T cell for liver cancer: a single-cell sequence based research
2个月前
已完结
Recommendations on Robotic Hepato-Pancreato-Biliary Surgery. The Paris Jury-Based Consensus Conference
3个月前
已完结
Anatomic Liver Resection Based on Portal Territory With Margin Priority for Hepatocellular Carcinoma
3个月前
已完结
Null-margin mesohepatectomy for centrally located hepatocellular carcinoma in cirrhotic patients
3个月前
已关闭
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy
3个月前
已完结
Survival benefit with IMRT following narrow‐margin hepatectomy in patients with hepatocellular carcinoma close to major vessels
3个月前
已完结
A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic or Open Liver Resection for Patients with BCLC Stage 0-A Hepatocellular Carcinoma
3个月前
已完结
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages
4个月前
已完结
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
8个月前
已完结
皖公网安备34019202002308
